Lanean...
Repeatability of tumor blood flow quantification with (82)Rubidium PET/CT in prostate cancer — a test-retest study
BACKGROUND: Non-invasive tumor blood flow (TBF) quantification is a candidate approach for risk stratification and monitoring of prostate cancer patients. Validation data have recently been published on prostate TBF measurement with the widely used positron emission tomography (PET) flow tracer (82)...
Gorde:
| Argitaratua izan da: | EJNMMI Res |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609677/ https://ncbi.nlm.nih.gov/pubmed/31273483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0529-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|